title: HGF/c-met/Stat3 signaling during skin tumor cell invasion: indications for a positive feedback loop.
abstract: BACKGROUND
  Stat3 is a cytokine- and growth factor-inducible transcription factor that regulates cell motility, migration, and invasion under normal and pathological situations, making it a promising target for cancer therapeutics. The hepatocyte growth factor (HGF)/c-met receptor tyrosine kinase signaling pathway is responsible for stimulation of cell motility and invasion, and Stat3 is responsible for at least part of the c-met signal.
  
  
  METHODS
  We have stably transfected a human squamous cell carcinoma (SCC) cell line (SRB12-p9) to force the expression of a dominant negative form of Stat3 (S3DN), which we have previously shown to suppress Stat3 activity. The in vitro and in vivo malignant behavior of the S3DN cells was compared to parental and vector transfected controls.
  
  
  RESULTS
  Suppression of Stat3 activity impaired the ability of the S3DN cells to scatter upon stimulation with HGF (c-met ligand), enhanced their adhesion, and diminished their capacity to invade in vitro and in vivo. Surprisingly, S3DN cells also showed suppressed HGF-induced activation of c-met, and had nearly undetectable basal c-met activity, as revealed by a phospho-specific c-met antibody. In addition, we showed that there is a strong membrane specific localization of phospho-Stat3 in the wild type (WT) and vector transfected control (NEO4) SRB12-p9 cells, which is lost in the S3DN cells. Finally, co-immunoprecipitation experiments revealed that S3DN interfered with Stat3/c-met interaction.
  
  
  CONCLUSIONS
  These studies are the first confirm that interference with the HGF/c-met/Stat3 signaling pathway can block tumor cell invasion in an in vivo model. We also provide novel evidence for a possible positive feedback loop whereby Stat3 can activate c-met, and we correlate membrane localization of phospho-Stat3 with invasion in vivo.
authors: Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center-Shreveport and Feist Weiller Cancer Center, Shreveport, Louisiana 71103, USA.
authors: Zanobia A
authors: ZA
authors: Syed
authors: Weihong
authors: W
authors: Yin
authors: Kendall
authors: K
authors: Hughes
authors: Jennifer N
authors: JN
authors: Gill
authors: Runhua
authors: R
authors: Shi
authors: John L
authors: JL
authors: Clifford
references: J Biol Chem. 1996 May 31;271(22):13221-7
references: 8675499
references: J Dermatol. 2005 May;32(5):354-60
references: 16043897
references: Curr Opin Genet Dev. 2000 Oct;10(5):503-7
references: 10980427
references: Nature. 1998 Jan 15;391(6664):285-8
references: 9440692
references: J Biol Chem. 2002 Apr 12;277(15):12931-6
references: 11812786
references: Sci STKE. 2006 Jul 11;2006(343):pe30
references: 16835434
references: Cancer Cells. 1991 Jun;3(6):227-32
references: 1832923
references: Int J Cancer. 1998 Oct 29;78(3):326-30
references: 9766567
references: Cancer Prev Res (Phila). 2009 Oct;2(10):903-11
references: 19789299
references: Mol Cancer. 2006 Apr 07;5:15
references: 16603078
references: Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7319-24
references: 11404481
references: Oncogene. 2000 Mar 16;19(12):1547-55
references: 10734314
references: Oncogene. 2006 May 4;25(19):2773-84
references: 16407846
references: J Cell Biol. 2006 Jan 16;172(2):245-57
references: 16401721
references: Oncogene. 2006 Feb 23;25(8):1195-204
references: 16205632
references: Mol Cell Biol. 1997 Sep;17(9):5307-16
references: 9271408
references: Curr Opin Cell Biol. 2001 Apr;13(2):211-7
references: 11248555
references: Biochem J. 2005 Dec 1;392(Pt 2):335-44
references: 16048438
references: Carcinogenesis. 2008 Jun;29(6):1108-14
references: 18453544
references: Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4138-43
references: 12640143
references: EXS. 1995;74:89-121
references: 8527903
references: Oncogene. 2000 May 15;19(21):2474-88
references: 10851046
references: Stem Cells. 2009 Oct;27(10):2383-92
references: 19658181
references: Nat Med. 2005 Jan;11(1):43-9
references: 15592573
references: J Biol Chem. 2001 Apr 13;276(15):12395-403
references: 11278729
references: Cell. 1999 Aug 6;98(3):295-303
references: 10458605
references: Mol Carcinog. 2007 Aug;46(8):725-31
references: 17610223
references: Oncogene. 2002 Mar 27;21(13):2000-8
references: 11960372
references: Cancer Res. 2004 Apr 1;64(7):2382-9
references: 15059889
references: Nat Rev Immunol. 2007 Jan;7(1):41-51
references: 17186030
references: Proc Natl Acad Sci U S A. 1995 Sep 26;92(20):9097-101
references: 7568080
references: Blood. 2003 Feb 15;101(4):1535-42
references: 12393476
references: Science. 2009 Feb 6;323(5915):793-7
references: 19131594
references: FEBS Lett. 1992 Apr 13;301(1):107-10
references: 1451778
references: Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10602-7
references: 15249664
references: Blood. 2003 Apr 1;101(7):2784-8
references: 12456503
references: J Dermatol Sci. 2008 Apr;50(1):1-14
references: 17601706
references: Mol Cell Biol. 2006 Jul;26(13):5155-67
references: 16782899
references: Nat Genet. 2001 May;28(1):29-35
references: 11326271
references: Clin Cancer Res. 2002 Jul;8(7):2067-72
references: 12114405
references: Nat Biotechnol. 2009 Oct;27(10):925-32
references: 19749770
references: Cancer Res. 2003 Oct 1;63(19):6272-81
references: 14559814
references: Oncogene. 2004 Apr 29;23(20):3550-60
references: 15116091
references: Oncogene. 2002 Jan 10;21(2):217-26
references: 11803465
references: Nat Med. 2005 Jun;11(6):595-6
references: 15937466
references: Neoplasia. 2005 Jun;7(6):545-55
references: 16036105
references: Cancer Res. 2009 Oct 1;69(19):7587-94
references: 19738054
references: J Clin Invest. 2004 Sep;114(5):720-8
references: 15343391
references: J Clin Invest. 2004 Sep;114(5):619-22
references: 15343379
references: Science. 2009 Jun 26;324(5935):1713-6
references: 19556508
references: J Clin Pathol. 2005 Aug;58(8):833-8
references: 16049285
references: Cancer Res. 2004 May 15;64(10):3550-8
references: 15150111
references: Mol Cancer Res. 2008 Oct;6(10):1521-33
references: 18922968
references: J Clin Invest. 2002 May;109(9):1139-42
references: 11994401
references: J Cell Biochem. 2005 Jul 1;95(4):805-16
references: 15838885
references: Cancer Res. 2002 Jun 15;62(12):3351-5
references: 12067972